Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease.The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology †, introducing aDBS for people living with Parkinson's. This feature personalizes ...

Penn State Health Milton S. Hershey Medical Center is Pennsylvania's first hospital to offer BrainSense adaptive deep brain ...